Depakene and Back pain aggravated - a phase IV clinical study of FDA data
Summary:
Back pain aggravated is reported as a side effect among people who take Depakene (valproic acid), especially for people who are female, 20-29 old, have been taking the drug for < 1 month also take Omeprazole, and have Depression.
The phase IV clinical study analyzes which people have Back pain aggravated when taking Depakene. It is created by eHealthMe based on reports of 14,611 people who have side effects when taking Depakene from the FDA, and is updated regularly.
What is Depakene?
Depakene has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 14,776 Depakene users. Check the latest studies of Depakene.
What is Back pain aggravated?
Back pain aggravated is found to be associated with 3,370 drugs and 2,093 conditions by eHealthMe. Check the latest studies of Back pain aggravated.
14,611 people reported to have side effects when taking Depakene.
Among them, 101 people (0.69%) have Back pain aggravated.
Among these 101 people:
How long have people been on Depakene when they have Back pain aggravated? *
What is the gender of people who have Back pain aggravated when taking Depakene? *
What is the age of people who have Back pain aggravated when taking Depakene? *
What are other drugs people take besides Depakene? *
What are other side effects people have besides Back pain aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Depakene and have Back pain aggravated?
- Check whether Back pain aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Depakene:
- Depakene (14,776 reports)
Back pain aggravated treatments and more:
- Back pain aggravated (152 reports)
How severe was Back pain aggravated and when was it recovered:
Expand to all the drugs that have ingredients of valproic acid:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Depakene:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Back pain aggravated:
- Back pain aggravated (3,370 drugs)
Browse all the conditions that are associated with Back pain aggravated:
- Back pain aggravated (2,093 conditions)
Related publications that referenced our studies
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on valproic acid (the active ingredients of Depakene) and Depakene (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Deltasone cause Abdominal Pain Lower? - 2 seconds ago
- Could Atropine cause Muscle Function Loss? - 2 seconds ago
- Could Neoral cause Ill-Defined Disorder? - 7 seconds ago
- Drug interactions of Esmolol Hydrochloride and Pantoprazole Sodium - 22 seconds ago
- Could Kanjinti cause Dyspnea? - 23 seconds ago
- Could Tenofovir Disoproxil Fumarate cause Nervous System Disorder? - 26 seconds ago
- Could Kaletra cause Hepatitis Aggravated? - 28 seconds ago
- Drug interactions of Ademetionine and Estazolam - 30 seconds ago
- Drug interactions of Levaquin and L-Lysine - 34 seconds ago
- Drug interactions of Fluoxetine Hydrochloride and Tpn - 37 seconds ago